Abstract：
:Adenoviral vectors deleted of E1 are attractive vehicles for in vivo gene therapy because efficient gene transfer can be achieved. Immune responses to the vector and vector-transduced cells lead to destruction of target cells, inflammation and difficulties with vector readministration. Immune effectors have been identified as CD8+ cytotoxic T lymphocytes, which destroy vector-transduced cells, as well as B cells which secrete neutralizing antibodies and block repeated gene transfer. The central role of CD4+ T cells in the activation of both of these effector functions has focused immunosuppressive strategies towards blockade of costimulatory molecules. We describe in this study a strategy which aims to inhibit CD4+ T cell activation by transiently administering an inhibitor of the CD28/B7 pathway, ie CTLA4Lg, at the time an E1-deleted adenovirus is administered to liver or lung. In lung, CTLA4Ig treatment significantly blocked the formation of neutralizing antibodies, allowing efficient readministration of virus, whereas transgene expression was only moderately prolonged. In contrast, CTLA4Ig did not suppress neutralizing antibody formation in the context of liver gene therapy, but resulted in more stable gene expression. In vitro assays revealed suppression of T cell activation in either organ. This observation suggests that transient inhibition of the CD28/B7 pathway at the time of virus instillation can partially interfere with both arms of the immune response to adenovirus-mediated gene transfer circumventing the need for chronic immune suppression.
journal_name
Gene Therjournal_title
Gene therapyauthors
Jooss K,Turka LA,Wilson JMdoi
10.1038/sj.gt.3300595subject
Has Abstractpub_date
1998-03-01 00:00:00pages
309-19issue
3eissn
0969-7128issn
1476-5462journal_volume
5pub_type
杂志文章相关文献
GENE THERAPY文献大全abstract：:Chimeric antigen receptor (CAR) T-cell therapies have demonstrated durable and potentially curative therapeutic efficacy against B-cell leukemia in clinical trials. A CAR strategy can target any tumor surface antigens as long as an antigen-binding receptor can be generated. New CARs that target solid tumors and have t...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.29
更新日期：2015-08-01 00:00:00
abstract：:Both atherosclerosis and arterial interventions induce oxidative stress mediated in part by nicotinamide adenine dinucleotide phosphate (NADPH) oxidases that have a pivotal role in the development of neointimal hyperplasia and restenosis. For small interfering RNA (siRNA) targeting of the NOX2 (Cybb) component of the ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.69
更新日期：2010-10-01 00:00:00
abstract：:Relaxin-3 is a neuropeptide that is abundantly expressed by discrete brainstem neuron populations that broadly innervate forebrain areas rich in the relaxin-3 G-protein-coupled-receptor, RXFP3. Acute and subchronic central administration of synthetic relaxin-3 or an RXFP3-selective agonist peptide, R3/I5, increase fee...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.83
更新日期：2013-07-01 00:00:00
abstract：:betaTC-tet cells are conditionally immortalized pancreatic beta cells which can confer long-term correction of hyperglycemia when transplanted in syngeneic streptozocin diabetic mice. The use of these cells for control of type I diabetes in humans will require their encapsulation and transplantation in non-native site...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300922
更新日期：1999-06-01 00:00:00
abstract：:We report on long-term delivery of an interferon-gamma (IFN gamma) inhibitory protein by intramuscular (i.m.) gene therapy. IFN gamma is a cytokine that plays an important role in many inflammatory disorders, including autoimmune insulin-dependent diabetes mellitus (IDDM) in NOD mice and (in various strains) multiple ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300879
更新日期：1999-05-01 00:00:00
abstract：:Virus-directed enzyme prodrug therapy utilizing the bacterial enzyme nitroreductase delivered by a replication-defective adenovirus vector to activate the prodrug CB1954 is a promising strategy currently undergoing clinical trials in patients with a range of cancers. Similarly, selectively replicating oncolytic adenov...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302510
更新日期：2005-08-01 00:00:00
abstract：:Lentiviral vectors pseudotyped with the baculovirus envelope protein GP64 transduce primary cultures of human airway epithelia (HAE) at their apical surface. Our goal in this study was to harness a directed evolution approach to develop a novel envelope glycoprotein with increased transduction properties for HAE. Usin...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2017.78
更新日期：2017-10-01 00:00:00
abstract：:We have constructed two recombinant adeno-associated virus (AAV) vectors (pJJ-3GC and pJJ-3ASA) which contained either the human glucocerebrosidase (GC) or arylsulfatase A (ASA) cDNA under the control of an SV40 promoter. These plasmids were co-transfected to 293 cells with a helper plasmid containing trans-acting AAV...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1994-07-01 00:00:00
abstract：:Adenovirus (Ad) vectors are of utility for many therapeutic applications. Strategies have been developed to alter adenoviral tropism to achieve a cell-specific gene delivery capacity employing fiber modifications allowing genetic incorporation of targeting motifs. In this regard, single chain antibodies (scFv) represe...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302603
更新日期：2006-01-01 00:00:00
abstract：:Antibodies have long been used in biomedical science as in vitro tools for the identification, purification and functional manipulation of target antigens; they have been exploited in vivo for diagnostic and therapeutic applications as well. Recent advances in antibody engineering have now allowed the genes encoding a...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3300346
更新日期：1997-01-01 00:00:00
abstract：:In 2012, we reported that 5 out of 11 subjects in a clinical trial (NCT00372320) administering AdhAQP1 to radiation-damaged parotid glands showed increased saliva flow rates and decreased symptoms over the initial 42 days. AdhAQP1 is a first-generation, E1-deleted, replication-defective, serotype 5 adenoviral vector e...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.55
更新日期：2015-09-01 00:00:00
abstract：:Newly isolated serotypes of AAV readily cross the endothelial barrier to provide efficient transgene delivery throughout the body. However, tissue-specific expression is preferred in most experimental studies and gene therapy protocols. Previous efforts to restrict gene expression to the myocardium often relied on dir...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.105
更新日期：2011-01-01 00:00:00
abstract：:There is growing interest in gene delivery to the eye in order to develop gene therapy for the many ocular disorders which may be amenable to this approach. To date, recombinant adenoviruses (AV) have been the main vector used for gene delivery to anterior and posterior segments in animal models. As with delivery to o...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300761
更新日期：1998-11-01 00:00:00
abstract：:Bone marrow presents an attractive option for the treatment of articular cartilage defects as it is readily accessible, it contains mesenchymal progenitor cells that can undergo chondrogenic differentiation and, once coagulated, it provides a natural scaffold that contains the cells within the defect. This study was p...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.16
更新日期：2010-06-01 00:00:00
abstract：:Adeno-associated virus (AAV)-mediated gene delivery systems have been shown to be effective tools for gene manipulation in the inner ear. For example, hair cells (HCs) and multiple other cell types can be transduced by the local injection of AAVs into the inner ear. However, application of the AAV-mediated CRISPR/Cas9...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-020-0124-1
更新日期：2020-08-01 00:00:00
abstract：:To identify the intracellular barriers to efficient gene transfer, we studied the intracellular trafficking of biotinylated plasmid DNA complexed with either fluorescein-conjugated lactosylated or mannosylated polylysine by confocal microscopy. Both are known to be taken up by cystic fibrosis airway epithelial cells (...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301768
更新日期：2002-08-01 00:00:00
abstract：:X-linked chronic granulomatous disease (X-CGD) is an inherited immunodeficiency with absent phagocyte NADPH-oxidase activity caused by defects in the gene-encoding gp91(phox). Here, we evaluated strategies for less intensive conditioning for gene therapy of genetic blood disorders without selective advantage for gene ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.96
更新日期：2009-12-01 00:00:00
abstract：:RNA interference (RNAi) is an evolutionarily conserved process by which plants and animals protect their genomes utilizing small, double-stranded RNAs to degrade target RNAs in a sequence-specific manner. Post-transcriptional gene silencing by these moieties can lead to degradation of both cellular and viral RNAs. It ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302339
更新日期：2004-12-01 00:00:00
abstract：:Sindbis virus expression has been used for in vitro investigations of antigen processing, presentation and epitope mapping. The recent development of a replication-deficient recombinant Sindbis virus expression vector has made in vivo expression possible with minimal pathogenic risk. Advantages of Sindbis virus over o...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300458
更新日期：1997-08-01 00:00:00
abstract：:To confer adenovirus vectors (AdV), the feature of integration into the host cell genome hybrid vectors were characterized in vitro, which express vectors derived from the prototypic foamy virus (FV) in the backbone of a high-capacity AdV. FVs constitute a subfamily of retroviruses with a distinct replication pathway ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302216
更新日期：2004-04-01 00:00:00
abstract：:Gene modification of malignant cells to express immune stimulators (cytokines and immune costimulators) has provided the basis for a novel form of immunotherapy. Using a MPSV-based retroviral vector with hygromycin resistance gene as a selectable marker, we have studied retrovirus-mediated gene transfer of an immune c...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300437
更新日期：1997-07-01 00:00:00
abstract：:We introduce an injectable system for the formation of a biodegradable DNA-containing implant that releases DNA over a 2-month period to provide a robust and prolonged gene expression at the site. Sustained delivery of the appropriate plasmid DNA resulted in sustained expression of luciferase, the persistent appearanc...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301786
更新日期：2002-09-01 00:00:00
abstract：:A persistent obstacle in the use of vector systems for gene therapy has been the inability to attain high-level expression of the target gene in primary cells in vivo. The MFG retroviral vector was designed to yield improved expression over the widely used N2 or LN vectors; however, the molecular basis for this effect...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1996-01-01 00:00:00
abstract：:Cationic liposomes provide a means to introduce genes into cells both ex vivo and in vivo. In the past few years their use has been described in several tissues, e.g. lungs, liver, endothelium, brain. In this study we evaluated a commercially available poly-cationic liposome formulation in delivering a reporter gene i...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1996-05-01 00:00:00
abstract：:Although systemic administration of neutralizing anti-TNF antibodies has been used successfully in treating rheumatoid arthritis, there is a potential for side effects. We transduced a collagen reactive T-cell hybridoma with tissue-specific homing properties to assess therapeutic effects of local delivery to inflamed ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301980
更新日期：2003-08-01 00:00:00
abstract：:The potential of gene therapy for treatment of lung disease remains unrealised. Early model systems often resulted in promising efficiency of gene transfer, only to prove irreproducible in the clinic. While problems such as induction of host immune responses and duration of expression also need to be addressed, it is ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301146
更新日期：2000-04-01 00:00:00
abstract：:For certain gene therapy applications, the simultaneous delivery of multiple genes would allow for novel therapies. In the case of adeno-associated virus (AAV) vectors, the limited packaging capacity greatly restricts current methods of carrying multiple transgene cassettes. To address this issue, a recombinant AAV (r...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.106
更新日期：2009-11-01 00:00:00
abstract：:The pseudorabies virus (PRV) is a swine alpha herpes virus that is widely used as a neural tracer because of its marked neurotropism and transneuronal transmissibility (Card et al., 1991, 1992; Strack and Loewy 1990). PRV has been used to retrogradely identify spinal cord and brainstem connections to various periphera...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1994-01-01 00:00:00
abstract：:Several groups are assessing the use of cationic lipids for respiratory gene therapy. To date no human data are available regarding the safety of intra-pulmonary cationic lipid delivery. In preparation for a trial of pulmonary delivery of the CFTR gene, we have assessed the safety of nebulised lipid GL-67/DOPE/DMPE-PE...
journal_title：Gene therapy
pub_type： 临床试验,杂志文章
doi：10.1038/sj.gt.3300481
更新日期：1997-09-01 00:00:00
abstract：:Vectors conjugated with ligands recognized by cell surface receptors are of interest for cystic fibrosis gene therapy since these vectors would allow cell-specific targeting. However, an efficient and specific uptake may be abrogated by a subsequent intracellular trafficking leading to an inefficient gene transfer. Th...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301738
更新日期：2002-06-01 00:00:00
